Ignite Creation Date:
2025-12-24 @ 2:06 PM
Ignite Modification Date:
2026-02-03 @ 7:28 AM
Study NCT ID:
NCT03170895
Status:
COMPLETED
Last Update Posted:
2020-03-30
First Post:
2017-05-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of Sorafenib and Omacetaxine Mepesuccinate in Newly Diagnosed or Relapsed/Refractory AML Carrying FLT3-ITD
Sponsor:
The University of Hong Kong
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-03-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-05-26
First Submit QC Date:
None
Study First Post Date:
2017-05-31
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-03-26
Last Update Post Date:
2020-03-30
Last Update Post Date Type:
ACTUAL